The national finals for the Nano Industry Technology Innovation category of the 11th China Innovation and Entrepreneurship Competition was held in Huangpu district, Guangzhou, from Dec 21 to 22.
Yunzhou Biotechnology (Guangzhou) recently cooperated with Lantu Biotech, which focuses on developing gene medicines, to attempt the first gene therapy for Menkes syndrome, a rare congenital disease that affects the metabolism of copper in the body.
Twelve firms in Guangzhou were recently rated as national technological innovation demonstration enterprises for 2022, with seven of them based in the Guangzhou High-tech Industrial Development Zone.
Huangpu-based enterprise Supertime was listed on the Shenzhen Stock Exchange on Nov 16. The securities are referred to as "Supertime" and the stock code is 301396.
In an evaluation conducted by financial industry media outlet Financial Vision China, Huangpu-based enterprise Science City (GZ) Financial Leasing won the Excellent Financial Leasing ABS Product Award for its Science City Leasing Asset-backed Special Plan project.
Guangzhou's Huangpu district has been accelerating the improvement of the quality and efficiency of incubators while serving the high-quality development of the real economy since the end of July.
In recent years, Huangpu district has been vigorously supporting small and medium-sized enterprises.
A total of seven companies from Guangzhou were selected, of which four are based in Guangzhou Development District, ranking first in the city.
Two companies in Guangzhou's Huangpu district, GAC Honda Automobile and Mars Wrigley Confectionery (China) Yonghe Branch, were recently included on the list of outstanding cases of national healthy enterprise construction, which consisted of a total of 100 cases.
Guangzhou KingMed Diagnostics Group has established 39 major medical laboratories and 670 rural medical laboratories across China, which carry out pathological analysis and detection, as well as provide related medical services to the public.